Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Dyne Therapeutics Inc., 3 years.
Dyne Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2026 | Dyne Therapeutics Inc. | Open-market sale | −1,359,674 | $25.00 | $33,991,850 |
| Aug 14, 2026 | Dyne Therapeutics Inc. | Open-market sale | −478,377 | $25.00 | $11,959,425 |
| Aug 14, 2026 | Dyne Therapeutics Inc. | Open-market sale | −322,465 | $25.00 | $8,061,625 |
| Aug 13, 2026 | Dyne Therapeutics Inc. | Open-market sale | −268,354 | $26.20 | $7,030,875 |
| Aug 13, 2026 | Dyne Therapeutics Inc. | Open-market sale | −94,415 | $26.20 | $2,473,673 |
| Aug 13, 2026 | Dyne Therapeutics Inc. | Open-market sale | −63,643 | $26.20 | $1,667,447 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −124,379 | $23.17 | $2,881,861 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −29,587 | $23.62 | $698,845 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −62,543 | $23.17 | $1,449,121 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −14,844 | $23.62 | $350,615 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −49,193 | $23.17 | $1,139,802 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −11,665 | $23.62 | $275,527 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −5,000 | $23.61 | $118,050 |
| Jul 6, 2026 | Dyne Therapeutics Inc. | Open-market sale | −253,039 | $22.79 | $5,766,759 |
| Jul 6, 2026 | Dyne Therapeutics Inc. | Open-market sale | −127,182 | $22.79 | $2,898,478 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.